Drawing for IMMUNOSCORE IC

USPTO serial 79342738

IMMUNOSCORE IC

Reviewed by CopyMark Law Group

Reg. 7318047Status 700Registered
Filing date
Status date
Registration date
Mar 5, 2024
Examiner
EISNACH, MICHAEL PATRICK
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IMMUNOSCORE IC?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rosaleen H. Chou

Rosaleen H. Chou Knobbe, Martens, Olson & Bear, LLP2040 Main Street, 14th FloorKnobbe, Martens, Olson & Bear, LLPIrvine, CA 92614

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products, namely, pharmaceutical products for use in the treatment of cancer; chemical preparations for medical and pharmaceutical use, namely for use in the treatment of cancer; biological reagents for medical use for providing information on diagnostics or identification of biological systems; biological reagents for providing information on diagnostics or identification of biological systems for medical use; immunological reagents for medical use; biological reagents for medical diagnosis; diagnostic kits comprising medical diagnostic reagents and medical diagnostic tests for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; biological reagents for medical research; biological reagents for medical use; biological reagents for clinical diagnosisACTIVE
009Downloadable or recorded software for diagnosis, prognosis, monitoring, prediction of reactions to treatment and continuous evaluation analysis and study of a cancer or tumors; downloadable application software in the field of clinical biology for diagnosis, prognosis, monitoring, prediction of reactions to treatment and continuous evaluation analysis and study of a cancer or tumorsACTIVE
042Research, development, technical design and scientific testing services, namely scientific research for relating to cancer treatment; industrial analysis and research services in the fields of immuno-oncology and cancer research; clinical trial services, namely providing laboratory testing in clinical trials; tests in laboratories, namely in the fields of immuno-oncology and cancer research; development of testing methods for others in the fields of immuno-oncology and cancer research; research, development, technical design, testing, consultancy and analysis services in the field of immuno-oncology; research services in the field of genome and immune index analysis; design and development of software in the field of biologyACTIVE
044Medical analysis services for the diagnosis of cancer and for the evaluation of a patient's reaction time to cancer treatments; medical assistance; medical diagnostics and diagnostics in the field of medicine, namely in the fields of immuno-oncology and cancer research; genetic analysis services, namely in the fields of immuno-oncology and cancer researchACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 14, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED
Jun 6, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 6, 2024FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 5, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 5, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 19, 2023GPNXNOTIFICATION PROCESSED BY IB
Dec 19, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 19, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 11, 2023OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Nov 29, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 29, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 29, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 22, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 22, 2023OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Nov 9, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Oct 19, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 18, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 18, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 10, 2023RFNTREFUSAL PROCESSED BY IB
Apr 18, 2023RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 18, 2023RFRRREFUSAL PROCESSED BY MPU
Feb 28, 2023RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 27, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 17, 2023DOCKASSIGNED TO EXAMINER
Jun 21, 2022MAFRAPPLICATION FILING RECEIPT MAILED
Jun 17, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 16, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance